BBOT
BridgeBio Oncology Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Eli Wallace
IPO Date
2025-08-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
BridgeBio Oncology Therapeutics Inc.
CEO
Eli Wallace
IPO Date
2025-08-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US